227 related articles for article (PubMed ID: 29750015)
1. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
[TBL] [Abstract][Full Text] [Related]
2. Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.
Breitinger U; Farag NS; Ali NKM; Breitinger HA
Biophys J; 2016 Jun; 110(11):2419-2429. PubMed ID: 27276260
[TBL] [Abstract][Full Text] [Related]
3. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
Breitinger U; Farag NS; Ali NKM; Ahmed M; El-Azizi MA; Breitinger HG
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33709903
[TBL] [Abstract][Full Text] [Related]
4. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
5. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
[TBL] [Abstract][Full Text] [Related]
6. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
Du QS; Huang RB; Wang SQ; Chou KC
PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
[TBL] [Abstract][Full Text] [Related]
7. Unusual architecture of the p7 channel from hepatitis C virus.
OuYang B; Xie S; Berardi MJ; Zhao X; Dev J; Yu W; Sun B; Chou JJ
Nature; 2013 Jun; 498(7455):521-5. PubMed ID: 23739335
[TBL] [Abstract][Full Text] [Related]
8. Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
Kolocouris A; Tzitzoglaki C; Johnson FB; Zell R; Wright AK; Cross TA; Tietjen I; Fedida D; Busath DD
J Med Chem; 2014 Jun; 57(11):4629-39. PubMed ID: 24793875
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
Zoidis G; Tsotinis A; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Org Biomol Chem; 2008 Sep; 6(17):3177-85. PubMed ID: 18698478
[TBL] [Abstract][Full Text] [Related]
10. In depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structure.
Du QS; Wang SQ; Chen D; Meng JZ; Huang RB
PLoS One; 2014; 9(4):e93613. PubMed ID: 24714586
[TBL] [Abstract][Full Text] [Related]
11. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Griffin S; Stgelais C; Owsianka AM; Patel AH; Rowlands D; Harris M
Hepatology; 2008 Dec; 48(6):1779-90. PubMed ID: 18828153
[TBL] [Abstract][Full Text] [Related]
12. Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.
Duque MD; Ma C; Torres E; Wang J; Naesens L; Juárez-Jiménez J; Camps P; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
J Med Chem; 2011 Apr; 54(8):2646-57. PubMed ID: 21466220
[TBL] [Abstract][Full Text] [Related]
13. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH
Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033
[TBL] [Abstract][Full Text] [Related]
14. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
Zoidis G; Kolocouris N; Naesens L; De Clercq E
Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900
[TBL] [Abstract][Full Text] [Related]
16. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
[TBL] [Abstract][Full Text] [Related]
17. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
Wang JF; Wei DQ; Chou KC
Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
[TBL] [Abstract][Full Text] [Related]
18. Computational Study of HCV p7 Channel: Insight into a New Strategy for HCV Inhibitor Design.
Ying B; Pang S; Yang J; Zhong Y; Wang J
Interdiscip Sci; 2019 Jun; 11(2):292-299. PubMed ID: 30194627
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
